Literature DB >> 31011776

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.

Donghee Kim1, Andrew A Li2, George Cholankeril1, Sun H Kim3, Erik Ingelsson4,5, Joshua W Knowles4,5, Robert A Harrington2, Aijaz Ahmed6,7.   

Abstract

AIMS/HYPOTHESIS: The determination of diabetes as underlying cause of death by using the death certificate may result in inaccurate estimation of national mortality attributed to diabetes, because individuals who die with diabetes generally have other conditions that may contribute to their death. We investigated the trends in age-standardised mortality due to diabetes as underlying or contributing cause of death and cause-specific mortality from cardiovascular disease (CVD), complications of diabetes and cancer among individuals with diabetes listed on death certificates in the USA from 2007 to 2017.
METHODS: Using the US Census and national mortality database, we calculated age-standardised mortality due to diabetes as underlying or contributing cause of death and cause-specific mortality rates among adults over 20 years with diabetes listed on death certificates. A total of 2,686,590 deaths where diabetes was underlying or contributing cause of death were analysed. We determined temporal mortality rate patterns by joinpoint regression analysis with estimates of annual percentage change (APC).
RESULTS: Age-standardised diabetes mortality rates compared among underlying cause of death, contributing cause of death and all-cause mortality were 32.2 vs 75.7 vs 105.1 per 100,000 individuals during the study period. The age-standardised mortality rates due to diabetes as underlying or contributing cause of death declined from 112.2 per 100,000 individuals in 2007 to 104.3 per 100,000 individuals in 2017 with the most pronounced decline noted from 2007 to 2014 (APC -1.4%; 95% CI -1.9%, -1.0%) and stabilisation in decline from 2014 to 2017 (APC 1.1%; 95% CI -0.6%, 2.8%). In terms of cause-specific mortality among individuals with diabetes listed on death certificates, the age-standardised mortality rates for CVD declined at an annual rate of 1.2% with a marked decline of 2.3% between 2007 and 2014. Age-standardised diabetes-specific mortality rates as underlying cause of death decreased from 2007 to 2009 (APC -4.5%) and remained stable from 2009 to 2017. Age-standardised mortality rates for cancer steadily decreased with an average APC of -1.4% (95% CI -1.8%, -1.0%) during the 11-year period. Mortality in the subcategory of CVD demonstrated significant differences. CONCLUSIONS/
INTERPRETATION: Current national estimates capture about 30% of all-cause mortality among individuals with diabetes listed as underlying or contributing cause of death on death certificates. The age-standardised mortality due to diabetes as underlying or contributing cause of death and cause-specific mortality from CVD in individuals with diabetes listed as underlying or contributing cause of death plateaued from 2014 onwards except for hypertensive heart disease and heart failure.

Entities:  

Keywords:  Cancer; Cardiovascular disease; Complication; Epidemiology; Mortality

Year:  2019        PMID: 31011776     DOI: 10.1007/s00125-019-4870-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

1.  Accuracy of death certificates for coding coronary heart disease as the cause of death.

Authors:  D M Lloyd-Jones; D O Martin; M G Larson; D Levy
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

2.  Diabetes mortality in the USA: winning the battle but not the war?

Authors:  Peter H Bennett
Journal:  Lancet       Date:  2018-05-18       Impact factor: 79.321

3.  Deaths: Leading Causes for 2015.

Authors:  Melonie Heron
Journal:  Natl Vital Stat Rep       Date:  2017-11

4.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

5.  Achievement of goals in U.S. diabetes care, 1999-2010.

Authors:  Mohammed K Ali; Kai McKeever Bullard; Jinan B Saaddine; Catherine C Cowie; Giuseppina Imperatore; Edward W Gregg
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

6.  Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.

Authors:  Linda S Geiss; Jing Wang; Yiling J Cheng; Theodore J Thompson; Lawrence Barker; Yanfeng Li; Ann L Albright; Edward W Gregg
Journal:  JAMA       Date:  2014-09-24       Impact factor: 56.272

7.  Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

Authors:  Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

8.  Estimating average annual per cent change in trend analysis.

Authors:  Limin X Clegg; Benjamin F Hankey; Ram Tiwari; Eric J Feuer; Brenda K Edwards
Journal:  Stat Med       Date:  2009-12-20       Impact factor: 2.373

9.  The Danish National Diabetes Register: trends in incidence, prevalence and mortality.

Authors:  B Carstensen; J K Kristensen; P Ottosen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2008-09-25       Impact factor: 10.122

10.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  6 in total

1.  Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017.

Authors:  Donghee Kim; George Cholankeril; Sun H Kim; Fahim Abbasi; Joshua W Knowles; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-17       Impact factor: 11.382

2.  Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018.

Authors:  Eugene Han; Sun Ok Song; Hye Soon Kim; Kang Ju Son; Sun Ha Jee; Bong-Soo Cha; Byung-Wan Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2022-06-29

3.  Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.

Authors:  Christine G Lee; Brandy Heckman-Stoddard; Dana Dabelea; Kishore M Gadde; David Ehrmann; Leslie Ford; Philip Prorok; Edward J Boyko; Xavier Pi-Sunyer; Amisha Wallia; William C Knowler; Jill P Crandall; Marinella Temprosa
Journal:  Diabetes Care       Date:  2021-10-25       Impact factor: 19.112

4.  Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States.

Authors:  Fan Lv; Xu Gao; Amy Huaishiuan Huang; Jian Zu; Xinyuan He; Xiaodan Sun; Jinli Liu; Ning Gao; Yang Jiao; Margaret G Keane; Lei Zhang; Yee Hui Yeo; Youfa Wang; Fanpu Ji
Journal:  EClinicalMedicine       Date:  2022-09-23

5.  Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States.

Authors:  Donghee Kim; Omar Alshuwaykh; Brittany B Dennis; George Cholankeril; Joshua W Knowles; Aijaz Ahmed
Journal:  Dig Liver Dis       Date:  2022-09-28       Impact factor: 5.165

6.  Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.

Authors:  Constance Stegbauer; Camilla Falivena; Ariadna Moreno; Anna Hentschel; Magda Rosenmöller; Tim Heise; Joachim Szecsenyi; Freimut Schliess
Journal:  BMC Health Serv Res       Date:  2020-11-16       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.